Biosynthesis of antibiotic chuangxinmycin from .
10.1016/j.apsb.2017.07.005
- Author:
Yuanyuan SHI
1
;
Zhibo JIANG
1
;
Xingxing LI
1
;
Lijie ZUO
1
;
Xuan LEI
1
;
Liyan YU
1
;
Linzhuan WU
1
;
Jiandong JIANG
1
;
Bin HONG
1
Author Information
1. Key Laboratory of Biotechnology of Antibiotics, the National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, China.
- Publication Type:Journal Article
- Keywords:
Actinoplanes tsinanensis;
Biosynthesis gene cluster;
Chuangxinmycin;
Cytochrome P450;
C–S bond formation;
Heterologous expression;
Seco-chuangxinmycin;
Sulfur incorporation
- From:
Acta Pharmaceutica Sinica B
2018;8(2):283-294
- CountryChina
- Language:English
-
Abstract:
Chuangxinmycin is an antibiotic isolated from CPCC 200056 in the 1970s with a novel indole-dihydrothiopyran heterocyclic skeleton. Chuangxinmycin showed antibacterial activity and efficacy in mouse infection models as well as preliminary clinical trials. But the biosynthetic pathway of chuangxinmycin has been obscure since its discovery. Herein, we report the identification of a stretch of DNA from the genome of CPCC 200056 that encodes genes for biosynthesis of chuangxinmycin by bioinformatics analysis. The designated cluster was then confirmed to be responsible for chuangxinmycin biosynthesis by direct cloning and heterologous expressing in M1146. The cytochrome P450 CxnD was verified to be involved in the dihydrothiopyran ring closure reaction by the identification of seco-chuangxinmycin in M1146 harboring the gene cluster with an inactivated . Based on these results, a plausible biosynthetic pathway for chuangxinmycin biosynthesis was proposed, by hijacking the primary sulfur transfer system for sulfur incorporation. The identification of the biosynthetic gene cluster of chuangxinmycin paves the way for elucidating the detail biochemical machinery for chuangxinmycin biosynthesis, and provides the basis for the generation of novel chuangxinmycin derivatives by means of combinatorial biosynthesis and synthetic biology.
